News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
569,523 Results
Type
Article (40863)
Company Profile (164)
Press Release (528496)
Section
Business (160551)
Career Advice (2457)
Deals (28961)
Drug Delivery (100)
Drug Development (74973)
Employer Resources (142)
FDA (13721)
Job Trends (12774)
News (283466)
Policy (27579)
Tag
Academia (2560)
Alliances (40987)
Alzheimer's disease (1341)
Approvals (13699)
Artificial intelligence (195)
Bankruptcy (311)
Best Places to Work (10399)
Biotechnology (138)
Breast cancer (214)
Cancer (1652)
Cardiovascular disease (134)
Career advice (2064)
CAR-T (122)
Cell therapy (352)
Clinical research (60408)
Collaboration (620)
Compensation (235)
COVID-19 (2491)
C-suite (170)
Data (1599)
Diabetes (206)
Diagnostics (5728)
Earnings (56736)
Employer resources (130)
Events (82614)
Executive appointments (570)
FDA (14565)
Funding (560)
Gene therapy (251)
GLP-1 (637)
Government (4117)
Healthcare (16294)
Infectious disease (2604)
Inflammatory bowel disease (121)
Interviews (520)
IPO (13141)
Job creations (2804)
Job search strategy (1698)
Layoffs (401)
Legal (5902)
Lung cancer (255)
Manufacturing (212)
Medical device (10580)
Medtech (10584)
Mergers & acquisitions (16168)
Metabolic disorders (538)
Neuroscience (1763)
NextGen: Class of 2025 (5694)
Non-profit (4022)
Northern California (1842)
Obesity (288)
Opinion (206)
Patents (158)
People (52746)
Phase I (18823)
Phase II (26638)
Phase III (20017)
Pipeline (700)
Postmarket research (2333)
Preclinical (7733)
Radiopharmaceuticals (218)
Rare diseases (314)
Real estate (4608)
Regulatory (19207)
Research institute (2178)
Resumes & cover letters (359)
Southern California (1641)
Startups (3014)
United States (16190)
Vaccines (572)
Weight loss (205)
Date
Last 7 days (526)
Last 30 days (2202)
Last 365 days (31343)
2025 (4027)
2024 (32053)
2023 (35749)
2022 (46409)
2021 (49887)
2020 (48046)
2019 (41004)
2018 (31079)
2017 (28225)
2016 (27012)
2015 (31460)
2014 (23955)
2013 (19526)
2012 (20906)
2011 (21902)
2010 (19580)
Location
Africa (748)
Arizona (135)
Asia (35213)
Australia (7172)
California (4227)
Canada (1583)
China (367)
Colorado (187)
Connecticut (197)
Europe (78368)
Florida (622)
Georgia (135)
Illinois (421)
Indiana (238)
Maryland (677)
Massachusetts (3080)
Michigan (178)
Minnesota (285)
New Jersey (1203)
New York (1212)
North Carolina (736)
Northern California (1842)
Ohio (144)
Pennsylvania (927)
South America (1040)
Southern California (1641)
Texas (630)
Utah (136)
Washington State (443)
569,523 Results for "chrysalis biotherapeutics formerly known as chrysalis biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit
Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in San Diego.
May 6, 2024
·
2 min read
Press Releases
Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury
November 18, 2024
·
2 min read
Drug Development
Chrysalis Receives FDA Approval to Initiate Clinical Trials with Chrysalin™ (TP508)
Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug Administration (FDA) has given the company permission to initiate human clinical trials aimed at treating acute lung failure.
September 26, 2023
·
2 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
February 21, 2025
·
3 min read
Press Releases
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
January 30, 2025
·
4 min read
Press Releases
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
January 30, 2025
·
4 min read
Press Releases
FORE Biotherapeutics to Participate in the Raymond James Private Biotech Symposium
February 14, 2025
·
1 min read
Press Releases
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
February 10, 2025
·
8 min read
1 of 56,953
Next
